Chimeric advanced drug delivery nano systems (chi-aDDnSs) for shikonin combining dendritic and liposomal technology

被引:34
|
作者
Kontogiannopoulos, Konstantinos N. [1 ]
Assimopoulou, Andreana N. [1 ]
Hatziantoniou, Sophia [2 ]
Karatasos, Kostas [3 ]
Demetzos, Costas [2 ]
Papageorgiou, Vassilios P. [1 ]
机构
[1] Aristotle Univ Thessaloniki, Dept Chem Engn, Organ Chem Lab, Thessaloniki 54124, Greece
[2] Univ Athens, Dept Pharmaceut Technol, Sch Pharm, GR-15771 Athens, Greece
[3] Aristotle Univ Thessaloniki, Dept Chem Engn, Phys Chem Lab, Thessaloniki 54124, Greece
关键词
Alkannin; Naphthoquinone; Liposome; Dendrimer; Hyperbranched polymers; Cancer; LOCKED-IN-DENDRIMERS; HYPERBRANCHED POLYESTERS; ANTITUMOR-ACTIVITY; PAMAM DENDRIMERS; RELEASE; POLYMERS; CHEMISTRY; ALKANNIN; VITRO; ISOHEXENYLNAPHTHAZARINS;
D O I
10.1016/j.ijpharm.2011.09.031
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The interest of drug delivery has focused on the creation of new formulations with improved properties, taking much attention to the drug release from the carrier. Liposomes have already been commercialized, while dendrimers and hyperbranched polymers are emerging as potentially ideal drug delivery vehicles. Chimeric advanced drug delivery nano systems (chi-aDDnSs) are mixed nanosystems combining different biomaterials that can offer advantages as drug carriers. Alkannin and shikonin (A/S) are naturally occurring hydroxynaphthoquinones with a well-established spectrum of wound healing, antimicrobial, anti-inflammatory, antioxidant and recently established antitumor activity. In this work three generations of hyperbranched aliphatic polyesters were used for the first time to form complexes with shikonin, as well as liposomal chi-aDDnSs. Characterization of the shikonin-loaded chi-aDDnSs was performed by measuring their particle size distribution, zeta-potential, drug encapsulation efficiency and the in vitro release profile. The analysis revealed sufficient drug encapsulation and appropriately featured release profiles. Chi-aDDnSs were also examined for their physical stability at 4 degrees C. The results are considered promising and could be used as a road map for designing in vivo experiments. (c) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:381 / 389
页数:9
相关论文
共 28 条
  • [1] New chimeric advanced Drug Delivery nano Systems (chi-aDDnSs) as doxorubicin carriers
    Gardikis, Konstantinos
    Tsimplouli, Chrisiida
    Dimas, Konstantinos
    Micha-Screttas, Maria
    Demetzos, Costas
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2010, 402 (1-2) : 231 - 237
  • [2] DPPC: MPOx chimeric advanced Drug Delivery nano Systems (chi-aDDnSs): Physicochemical and structural characterization, stability and drug release studies
    Pippa, Natassa
    Merkouraki, Maria
    Pispas, Stergios
    Demetzos, Costas
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2013, 450 (1-2) : 1 - 10
  • [3] The imaging and the fractal metrology of chimeric liposomal Drug Delivery nano Systems: the role of macromolecular architecture of polymeric guest
    Pippa, Natassa
    Pispas, Stergios
    Demetzos, Costas
    JOURNAL OF LIPOSOME RESEARCH, 2014, 24 (03) : 223 - 229
  • [4] Bio-inspired Chimeric Drug Delivery nano Systems (Chi-DDnSs): Their Fractal Hologram and Regulatory Aspects
    Pippa, Natassa
    Pispas, Stergios
    Demetzos, Costas
    GENEDIS 2014: NEURODEGENERATION, 2015, 822 : 199 - 200
  • [5] The physicochemical/thermodynamic balance of advanced drug liposomal delivery systems
    Pippa, Natassa
    Gardikis, Konstantinos
    Pispas, Stergios
    Demetzos, Costas
    JOURNAL OF THERMAL ANALYSIS AND CALORIMETRY, 2014, 116 (01) : 99 - 105
  • [6] The physicochemical/thermodynamic balance of advanced drug liposomal delivery systems
    Natassa Pippa
    Konstantinos Gardikis
    Stergios Pispas
    Costas Demetzos
    Journal of Thermal Analysis and Calorimetry, 2014, 116 : 99 - 105
  • [7] Microbial biosensors to monitor the encapsulation effectiveness of Doxorubicin in chimeric advanced Drug Delivery Nano Systems: A calorimetric approach
    Gardikis, Konstantinos
    Signorelli, Marco
    Ferrario, Chiara
    Schiraldi, Alberto
    Fortina, Maria Grazia
    Hatziantoniou, Sophia
    Demetzos, Costas
    Fessasa, Dimitrios
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2017, 516 (1-2) : 178 - 184
  • [8] DPPC:MPOx chimeric nanocontainers: the fractal sculpture of novel advanced drug delivery nano systems and drug release studies.
    Merkouraki, Maria
    Pippa, Natassa
    Pispas, Stergios
    Demetzos, Costas
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2013, 50 : E192 - E192
  • [9] New Drug Delivery Nanosystem Combining Liposomal and Dendrimeric Technology (Liposomal Locked-In Dendrimers) for Cancer Therapy
    Gardikis, Konstantinos
    Hatziantoniou, Sophia
    Bucos, Madalina
    Fessas, Dimitrios
    Signorelli, Marco
    Felekis, Theodoros
    Zervou, Maria
    Screttas, Constantinos G.
    Steele, Barry R.
    Ionov, Maksim
    Micha-Screttas, Maria
    Klajnert, Barbara
    Bryszewska, Maria
    Demetzos, Costas
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2010, 99 (08) : 3561 - 3571
  • [10] PEO-b-PCL Grafted DPPC Liposomes: Physicochemical Characterization and Stability Studies of Novel Bio-Inspired Advanced Drug Delivery Nano Systems (aDDnSs)
    Pippa, Natassa
    Deli, Eleni
    Mentzali, Evangelia
    Pispas, Stergios
    Demetzos, Costas
    JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY, 2014, 14 (08) : 5676 - 5681